AuntMinnie

JULY 12, 2024

As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. Image courtesy of Washington University. "We This oversight has led to program launch setbacks, Beyder explained.

Nuclear Medicine 105

Nuclear Medicine Radiation Oncology Radiopharmaceuticals Radiation 105

Imaging Technology

JULY 9, 2024

I am excited and honored to assume the role of CEO at Blue Earth Diagnostics,” said Campione in the written statement released today. Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A., Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A., Bracco Imaging S.p.A.,

Diagnostic 105

Diagnostic Radiopharmaceuticals Nuclear Medicine Magnetic Resonance Imaging 105

Imaging Technology

DECEMBER 27, 2023

Naeger, MD , as the 2024 ARRS Distinguished Educator. Dr. Naeger has disseminated to countless radiologists and other health professionals the most current scientific and clinical information regarding diagnostic imaging, image-guided intervention, and related fields.

Education 104

Education Nuclear Medicine Inpatient Radiology 104

AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. This drug relies on a gallium Ga-68, too, as a diagnostic imaging agent.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

Imaging Technology

JUNE 12, 2024

The company reports it is a worldwide leader in the clinical use of AI to improve diagnoses with one of the largest global deployments to enhance early breast cancer detection and in the evaluation of brain disorders. More information: www.SimonMed.com Wednesday, June 12, 2024 - 11:45

Disease 116

Disease Magnetic Resonance Imaging Nuclear Medicine Imaging 116

AuntMinnie

JUNE 20, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. This drug relies on a gallium Ga-68, too, as a diagnostic imaging agent.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

Imaging Technology

JUNE 20, 2024

More than half of the world’s population is underserved and lacks access to essential health services, and two-thirds have no access to diagnostic imaging. Additionally, with technology advancements and software upgrades, the lifespan of equipment can be extended and enhanced to help improve clinical outcomes.

Healthcare 104

Healthcare Healthcare Nuclear Medicine Computed Tomography 104